Chemical formula: C₁₆H₁₃ClN₂O₂ Molecular mass: 300.74 g/mol PubChem compound: 5391
Temazepam is a benzodiazepine with hypnotic and sedative effects as well as anxiolytic activity. Temazepam effects are likely to be due to potentiation of gamma-aminobutyric acid (GABA), although other neurotransmitters may also be affected.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| N05CD07 | Temazepam | N Nervous system → N05 Psycholeptics → N05C Hypnotics and sedatives → N05CD Benzodiazepine derivatives |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| TEMAZEPAM Uncoated tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| RESTORIL Capsule | FDA, National Drug Code (US) | MPI, US: SPL/Old |
Temazepam is an active ingredient of these brands:
United States (US)Canada (CA)Germany (DE)Ireland (IE)New Zealand (NZ)South Africa (ZA)Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
